Memory generalization is selectively altered in the psychosis dimension

1 Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial Schizophrenia Research, May 6, 2013

2 Open-label pilot study on vitamin D3 supplementation for antipsychotic-associated metabolic anomalies International Clinical Psychopharmacology, May 22, 2013

3 Benzodiazepines for psychosis-induced aggression or agitation Cochrane Reviews, May 8, 2013

4 Challenges in the Treatment of Major Depressive Disorder With Psychotic Features Schizophrenia Bulletin, April 24, 2013    Review Article

5 The schizoaffective disorder diagnosis: a conundrum in the clinical setting European Archives of Psychiatry and Clinical Neuroscience, May 1, 2013    Review Article

6 Differences in associations between cannabis and stimulant disorders in first admission psychosis Schizophrenia Research, May 17, 2013

7 Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders Neuropsychiatric Disease and Treatment, May 6, 2013

8 Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders General Hospital Psychiatry, May 7, 2013

9 Informing DSM 5: Biological boundaries between Bipolar I, Schizoaffective, and Schizophrenia BMC Medicine, May 16, 2013

10 Naturalistic outcomes of community treatment orders: antipsychotic long-acting injections versus oral medication Journal of Psychopharmacology, May 17, 2013